D Reimer
Overview
Explore the profile of D Reimer including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
23
Citations
539
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Franco B, Blumenstock T, Cho C, Clarisse L, Clerbaux C, Coheur P, et al.
Nature
. 2021 May;
593(7858):233-237.
PMID: 33981052
Atmospheric acidity is increasingly determined by carbon dioxide and organic acids. Among the latter, formic acid facilitates the nucleation of cloud droplets and contributes to the acidity of clouds and...
2.
Vereecken L, Carlsson P, Novelli A, Bernard F, Brown S, Cho C, et al.
Phys Chem Chem Phys
. 2021 Mar;
23(9):5496-5515.
PMID: 33650589
The initial stages of the nitrate radical (NO3) initiated oxidation of isoprene, in particular the fate of the peroxy (RO2) and alkoxy (RO) radicals, are examined by an extensive set...
3.
Ickert C, Cheng J, Reimer D, Greig J, Hexemer A, Kershaw T, et al.
Epidemiol Infect
. 2019 Sep;
147:e280.
PMID: 31558173
Enteric illness outbreaks are complex events, therefore, outbreak investigators use many different hypothesis generation methods depending on the situation. This scoping review was conducted to describe methods used to generate...
4.
Oskay-Ozcelik G, Alavi S, Richter R, Keller M, Chekerov R, Cecere S, et al.
Ann Oncol
. 2018 Feb;
29(4):910-916.
PMID: 29415128
Backround: The primary aim of this study was to investigate information needs and treatment preferences of patients with ovarian cancer, focusing especially on physician-patient relationship and treatment. Patients And Methods:...
5.
Marth C, Reimer D, Zeimet A
Ann Oncol
. 2017 Dec;
28(suppl_8):viii36-viii39.
PMID: 29232473
Paclitaxel and carboplatin combination chemotherapy has remained the standard of care in the front-line therapy of advanced epithelial ovarian cancer during the last decade. Maintenance chemotherapy has not been proven...
6.
Schlag P, Rubach F, Mentel T, Reimer D, Canonaco F, Henzing J, et al.
Faraday Discuss
. 2017 Jun;
200:331-351.
PMID: 28580998
Ambient measurements of PM aerosol chemical composition at Cabauw, the Netherlands, implicate higher ammonium concentrations than explained by the formation of inorganic ammonium salts. This additional particulate ammonium is called...
7.
Sehouli J, Reinthaller A, Marth C, Reimer D, Reimer T, Stummvoll W, et al.
Br J Cancer
. 2014 Sep;
111(8):1519-25.
PMID: 25225907
Background: This is the first study investigating the safety and efficacy of the trifunctional antibody catumaxomab administered i.p. at the end of cytoreductive surgery and postoperatively prior to standard chemotherapy...
8.
Zeimet A, Reimer D, Sopper S, Boesch M, Martowicz A, Roessler J, et al.
Neoplasma
. 2012 Aug;
59(6):747-55.
PMID: 22862176
Because of its semi-solid character in dissemination and growth, advanced ovarian cancer with its hundreds of peritoneal tumor nodules and plaques appears to be an excellent in vivo model for...
9.
Reimer D, Hubalek M, Kiefel H, Riedle S, Skvortsov S, Erdel M, et al.
Oncogene
. 2011 Apr;
30(38):4038-49.
PMID: 21516127
Recently we showed an integral epidermal growth factor receptor (EGFR)-E2F3a signaling path, in which E2F3a was found to be essential in EGFR-mediated proliferation in ovarian cancer cells. The present work...
10.
Hofstetter G, Berger A, Fiegl H, Slade N, Zoric A, Holzer B, et al.
Oncogene
. 2010 Jan;
29(13):1997-2004.
PMID: 20101229
Similar to p73, the tumor suppressor gene p53 is subject to alternative splicing. Besides p53DeltaE6 and p53beta, we identified p53zeta, p53delta and p53varepsilon, arising from alternative splicing of exon 6...